Adcock Richard

Adcock Richard is listed in filings as CEO & President at ImmunityBio, Inc.. This profile follows SEC Form 4 activity through Feb 24, 2026, including 12 public disclosures. Recent filings connect the profile to ImmunityBio, Inc. (IBRX). The current snapshot covers public activity from Jan 3, 2025 to Feb 24, 2026. Reported amounts are shown as $674.8K to $34.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.